Sfoglia per AUTORE
DI FIORE P
Collezione ASL Asti

  

Items : 9

Late response to anti-CGRP (calcitonin gene-related peptide) monoclonal antibodies: implication for clinical practice in European Journal of Neurology

2022
ASL Asti

Aurilia C; Egeo G; Fiorentini G; Cevoli S; Messina R; Salerno A; Torelli P; Albanese M; Carnevale A; Bono F; D'Amico D; Altamura C; Colombo B; Frediani F; Mercuri B; D'Onofrio F; Grazzi L; Aguggia M; Finocchi C; Di Fiore P; Zucco M; Trimboli M; Bonassi S; Vernieri F; Barbanti P;

Predictors of response to antiCGRP monoclonal antibodies: a multicenter, 24-week, cohort study on 864 migraine patients in European Journal of Neurology

2022
ASL Asti
ASL Vercelli

Egeo G; Aurilia C; Cevoli S; Fiorentini G; Altamura C; Finocchi C; Di Clemente L; Zucco M; Raniero A; Trimboli M; Bono F; Filippi M; Proietti S; Bonassi S; Le Pera D; Albanese M; Grazzi L; Di Fiore P; D'Onofrio F; Aguggia M; Colombo B; Torelli P; Vernieri F; Barbanti P;

Late response to anti-CGRP monoclonal antibodies occurs in one-third of migraine patients in Headache

2022
ASL Asti

Aurilia C; Egeo G; Fiorentini G; Cevoli S; Messina R; Torelli P; Salerno A; Albanese M; Carnevale A; d'Onofrio F; Finocchi C; Altamura C; Aguggia M; Mercuri B; Bono F; Grazzi L; D'Amico D; Filippi M; Colombo B; Frediani F; Favoni V; Di Fiore P; Bertuzzo D; Zucco M; Di Clemente L; Trimboli M; Proietti S; Bonassi S; Vernieri F; et alii...

Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study in European Journal of Neurology

2022
ASL Asti

Vernieri F; Altamura C; Brunelli N; Costa CM; Aurilia C; Egeo G; Fofi L; Favoni V; Lovati C; Bertuzzo D; d’Onofrio F; Doretti A; Di Fiore P; Finocchi C; Schiano Di Cola F; Ranieri A; Colombo B; Bono F; Albanese M; Cevoli S; Barbanti P; Pierangeli G; Capogrosso C; Aguggia M; Spitaleri D; Messina S; Trogu F; Frediani F; Baldi O; et alii...

Long term (48-weeks) effectiveness, safety and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in real-world: The early 2 study in Journal of the Neurological Sciences

2021
ASL Asti

Aurilia C; Cevoli S; Egeo G; Fofi L; Messina R; Salerno A; Torelli P; Albanese M; Carnevale A; Bono F; D'Amico D; Filippi M; Altamura C; Vernieri F; Colombo B; Frediani F; Mercuri B; D'Onofrio F; Grazzi L; Aguggia M; Favoni V; Finocchi C; Di Fiore P; Costa CM; Brunelli N; Fallacara A; Bertuzzo D; Zucco M; Di Clemente L; et alii...

Long-term (>48 weeks) safety and tolerability of erenumab in reallife in Journal of Headache and Pain

2021
ASL Asti

Aurilia C; Cevoli S; Egeo G; Fofi L; Messina R; Salerno A; Torelli P; Albanese M; Carnevale A; Bono F; D'Amico D; Filippi M; Altamura C; Vernieri F; Colombo B; Frediani F; Mercuri B; D'Onofrio F; Grazzi L; Aguggia M; Favoni V; Finocchi C; Di Fiore P; Costa CM; Brunelli N; Fallacara A; Bertuzzo D; Zucco M; Di Clemente L; et alii...

Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) in Journal of Headache and Pain

2021
ASL Asti

Vernieri F; Altamura C; Brunelli N; Costa CM; Aurilia C; Egeo G; Fofi L; Favoni V; Pierangeli G; Lovati C; Aguggia M; d’Onofrio F; Doretti A; Di Fiore P; Finocchi C; Rao R; Bono F; Ranieri A; Albanese M; Cevoli S; Barbanti P; Capogrosso C; Bertuzzo D; Spitaleri D; Messina S; Trogu F; Frediani F; Baldi O; Di Cola FS; et alii...

GalcanezumAb for prevention of high frequency episodic and chronic migraine in the Real Life in ITaly: A multicenter prospective cohort study (the GARLIT study) in Cephalalgia

2021
ASL Asti

Vernieri F; Altamura C; Brunelli N; Costa CM; Aurilia C; Egeo G; Fofi L; Favoni V; Pierangeli G; Lovati C; Aguggia M; Bertuzzo D; D'Onofrio F; Doretti A; Di Fiore P; Frediani F; Finocchi C; Rao R; Schiano Di Cola F; Bono F; Ranieri A; Albanese M; Cevoli S; Barbanti P;

Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study). in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Dec;41(Suppl 2):487-488. doi: 10.1007/s10072-020-04669-y.

2020
ASL Asti

Vernieri F; Altamura C; Aurilia C; Brunelli N; Egeo G; Fofi L; Costa CM; Fallacara A; Favoni V; Pierangeli G; Aguggia M; Bertuzzo D; Albanese M; Di Fiore P; Frediani F; Cevoli S; Barbanti P;